TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
ELTX

Elicio Therapeutics Inc.

Healthcare · Biotechnology

1.90$ +0.0% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement ELTX
Line item 2012 2013 2018 2019 2020 2021 2022 2023 2024 2025
-9.8% -38.8% -63.1% +93.7% +883.1% -100.0%
-13.6% -88.0% +198.9% +60.0% -32.1% -14.3% +10.7% +0.7% -4.2%
-6.0% +7.1% -90.4% +202.6% +2,449.7% -103.9%
+4,568.7% +225.5% +30.5% +25.0% -64.9% +33.0% +48.4% -26.0%
+7.2% +151.3% -25.4% +111.3% -4.8% +13.1%
-5.9% +372.8% +116.5% +44.7% +17.8% -65.8% +52.5% +26.7% -16.5%
-2.3% -90.1% +310.3% -70.5% -57.0% +149.0%
+45.1% -1,255.9%
+124.3% -89.0% +9,701.4% +310.3%
+105.7% -3,267.3%
-96.8% -23,029.3%

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?